Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 7, 2011

View Archived Issues

Esmirtazapine may impair day-after driving performance

Yokukansan ameliorates aspects of two autism spectrum disorders

SHIFT substudy evaluates ivabradine in patients on background therapy for heart failure

Doxazosin versus tizanidine assessed in children with voiding dysfunction

Merck & Co. reports discovery of new tachykinin NK1 receptor antagonists

EVOLVE-1 trial assesses mTOR inhibitor plus best supportive care in hepatocellular carcinoma

Merck KGaA presents novel TGFR-1 inhibitors

KBP Biosciences patents novel antibacterial prodrugs of carbapenem derivatives

New prostaglandin E synthase inhibitors synthesized

Elevation Pharmaceuticals begins phase II trial of nebulized EP-101 in COPD

New substituted trifluoromethanes disclosed

Completed phase IIa study provides promising data on VX-509 in rheumatoid arthritis

Durect advances U.S. phase III Posidur trial

Adolor completes reacquisition of all rights to alvimopan

BioDelivery Sciences reports preliminary phase I data on BEMA-buprenorphine/naloxone

RIKEN identifies novel IFN-gamma inducers

Discovery Labs submits complete response to FDA for Surfaxin

Theratechnologies initiates new phase II tesamorelin study

Boehringer Ingelheim provides updates on two phase II afatinib trials in breast cancer

Basilea Pharmaceutica begins second phase I trial of sulfactam antibiotic BAL-30072

Furiex reports promising phase II data on MuDelta in D-IBS

SARcode BioScience initiates phase III trial of SAR-1118 ophthalmic solution

European Commission grants PUMA for Buccolam

AB Science commences enrollment in international masitinib trial in MS

MediGene and Pharmanova enter agreement for Veregen

University of Pennsylvania awards grant to OPKO for MPS I therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...